GI & Endoscopy

Exact Sciences provided the Kentucky Department for Public Health a grant for 1,000 Cologuard kits, the department announced Jan. 20.

A study of Kaiser Permanente members in Southern California found that offering patients to self-order a colorectal cancer screening test online increases rates of test completion, according to a Jan. 21 news release.

Here are the most-read GI articles during the week of Jan. 18-22:

The FDA declined to extend National Coverage Determination to Epigenomics AG for its Epi proColon, a blood-based colorectal cancer screening test, the company announced Jan. 21.

Barrett's esophagus patients may be more vulnerable to COVID-19 infection in their upper gastrointestinal tract after eating or drinking food contaminated with the virus, according to a study published Jan. 20 in Gastroenterology.

Patients who received an outpatient colonoscopy seldom go to the emergency rooms for unplanned complications, and of those who do it's often for reasons unrelated to the procedure, according to a study published in Clinical and Experimental Gastroenterology.

Gastroenterologist Farid Namin, MD, opened a personal protective equipment manufacturer after overcoming procurement obstacles early in the pandemic, the Kansas City Business Journal reported Jan. 19.

Here are five updates from GI practices and companies from the past week:

Investing firm Assured Healthcare Partners and West Long Branch, N.J.-based Allied Digestive Health struck a deal Jan. 13.

GI Alliance partnered with ObvioHealth, a research organization, to create decentralized clinical trial designs, according to a Jan. 19 news release.